Cargando…
Review of the History and Current Status of Cell-Transplant Approaches for the Management of Neuropathic Pain
Treatment of sensory neuropathies, whether inherited or caused by trauma, the progress of diabetes, or other disease states, are among the most difficult problems in modern clinical practice. Cell therapy to release antinociceptive agents near the injured spinal cord would be the logical next step i...
Autores principales: | Eaton, Mary J., Berrocal, Yerko, Wolfe, Stacey Q., Widerström-Noga, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382629/ https://www.ncbi.nlm.nih.gov/pubmed/22745903 http://dx.doi.org/10.1155/2012/263972 |
Ejemplares similares
-
Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines
por: Eaton, Mary J., et al.
Publicado: (2012) -
Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord Injury
por: Eaton, Mary J., et al.
Publicado: (2011) -
Deep Brain Stimulation Improves the Symptoms and Sensory Signs of Persistent Central Neuropathic Pain from Spinal Cord Injury: A Case Report
por: Jermakowicz, Walter J., et al.
Publicado: (2017) -
The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update
por: Loh, Eldon, et al.
Publicado: (2022) -
Editorial: Translational research in neuropathic pain: Current status and future directions
por: Karri, Jay, et al.
Publicado: (2022)